News from bonesupport A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 22, 2017, 03:00 ET BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection,...

Apr 11, 2017, 02:00 ET BONESUPPORT™ Appoints Michael Diefenbeck as Chief Medical Officer

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...

Mar 16, 2017, 03:00 ET BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...

Mar 14, 2017, 03:00 ET BONESUPPORT™ Extends U.S. Distribution Agreement for CERAMENT™|BONE VOID FILLER

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...

Dec 16, 2016, 09:00 ET BONESUPPORT Confirms Election of Dr. Håkan Björklund as Chairman of the Board

Tone Kvåle, CFO of Nordic Nanovector, elected as a new Board Member BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone...

Dec 13, 2016, 11:54 ET Richard Davies Wins 'Best CEO in the Biomaterials Industry' Award From European CEO Magazine

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or...

Nov 07, 2016, 08:00 ET BONESUPPORT™ Announces Key Corporate Appointment To Drive Growth In North America

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone graft substitutes to treat bone voids caused by trauma, infection,...

Oct 26, 2016, 06:01 ET BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT™ Injectable Drug Eluting Bioceramic Platform

-Dr. Håkan Björklund of Tellacq AB, former CEO of Nycomed, becomes Chairman-Elect - CERAMENT BVF, CERAMENT G AND CERAMENT V continue to increase...

Sep 01, 2016, 09:12 ET BONESUPPORT™'s CERAMENT™|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis - Results From Prospective Study of 100 Patients Published in The Bone and Joint Journal

Single Stage Surgical Procedure Achieves 96% Infection Eradication Rate BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable...

Aug 30, 2016, 09:00 ET BONESUPPORT™'s CERAMENT™|G and CERAMENT™ V to be Featured Extensively at the 35th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Oxford, UK

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection,...

Aug 09, 2016, 09:03 ET BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study

FORTIFY Study to Assess CERAMENT G as Part of Surgical Repair of OpenDiaphyseal Tibial Fractures BONESUPPORT AB, an emerging leader in innovative...

Mar 01, 2016, 09:30 ET BONESUPPORT™ macht CERAMENT™|G entsprechend der gestiegenen Marktnachfrage in Europa als 5 ml-Größe verfügbar

Mar 01, 2016, 09:30 ET BONESUPPORT™ Announces Availability In Europe Of CERAMENT™|G In 5 mL Volume To Address Growing Market Demand

BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to...

Mar 01, 2016, 09:30 ET BONESUPPORT™ annonce la disponibilité en Europe de CERAMENT™|G sous volume de 5 ml afin de répondre à une demande croissante du marché

Mar 01, 2016, 09:30 ET BONESUPPORT™ anuncia la disponibilidad en Europa de CERAMENT™|G en un volumen de 5 mL

Feb 02, 2016, 09:30 ET BONESUPPORT™ annonce l'extension du registre des procédures de la société portant sur CERAMENT™, un produit à élution de medicaments

Feb 02, 2016, 09:30 ET BONESUPPORT™ anuncia la expansión del registro del procedimiento liberador de fármaco CERAMENT™

Feb 02, 2016, 09:30 ET BONESUPPORT™ Reports Expansion Of Company's CERAMENT™ Drug Eluting Procedure Registry

BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to...

Feb 02, 2016, 09:30 ET BONESUPPORT™ meldet Ausweitung des Registers für CERAMENT™ Arzneimittel freisetzende Verfahren

Jan 22, 2016, 09:30 ET BONESUPPORT™ gibt Ernennung von Richard Davies, Veteran der Life-Sciences-Branche, zum neuen Chief Executive Officer bekannt

Jan 22, 2016, 09:30 ET BONESUPPORT™ anuncia el nombramiento de Richard Davies, como nuevo consejero delegado

Jan 22, 2016, 09:30 ET BONESUPPORT™ Announces Appointment Of Life Sciences Industry Veteran, Richard Davies, As New Chief Executive Officer

BONESUPPORT™, an emerging leader in both injectable bone substitutes and innovative drug eluting bone scaffold technology for orthopedic trauma, bone ...

Jan 22, 2016, 09:30 ET BONESUPPORT™ annonce la nomination au poste de PDG du vétéran du secteur des sciences de la vie Richard Davies

Jan 11, 2016, 09:30 ET BONESUPPORT™ Announces 20,000 Patients Now Treated With CERAMENT™

BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to...

Jan 11, 2016, 09:30 ET BONESUPPORT™ gibt Behandlung von bisher 20.000 Patienten mit CERAMENT™ bekannt